Medtronic Is About to Report Its First Earnings Since Spinning Off MiniMed. Should You Buy the Stock Before Nov. 24?

Source Motley_fool

Key Points

  • Medtronic concluded its spin-off of MiniMed in October.

  • Investors will expect rising sales and stabilizing margins in its upcoming report.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

Medtronic (NYSE:MDT), one of the world's largest medical device makers, will post its next earnings report on Nov. 24. It will mark its first earnings report after it spun off its diabetes unit, MiniMed (NASDAQ:MMED), and fully removed its business from its balance sheet.

Woman working on a laptop at a desk with financial trading charts on a large monitor.

Image source: Getty Images.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

What are analysts expecting?

In fiscal 2023 and fiscal 2024 (which ended in April 2024), Medtronic's earnings declined as it struggled with supply chain constraints, inflation, forex headwinds, regulatory challenges for its diabetes business, and lumpy post-pandemic recovery in elective procedures. Tougher competition, quality control issues, and new GLP-1 drugs exacerbated that pressure.

But in fiscal 2025 and fiscal 2026, its earnings grew again as it stabilized its costs, expanded its higher-growth cardiovascular and neuroscience businesses, and spun off MiniMed. In fiscal 2026, its revenue grew 5.8% organically, marking its strongest top-line growth in a decade. For fiscal 2027, it expects its revenue to rise another 7.25%-7.75%.

Should you buy Medtronic before Nov. 24?

For the third quarter of fiscal 2027, analysts expect Medtronic's revenue to rise 6% year over year but for its adjusted EPS to dip 2%. Its cardiovascular and neuroscience businesses should remain strong. Still, the completion of its MiniMed spin-off (which concluded on Oct. 15), its reinvestment in higher-growth platforms, early-stage manufacturing costs for newer cardiovascular devices, and a few recent acquisitions are squeezing its margins.

Medtronic's stock looks cheap at 17 times forward earnings and pays a forward yield of 2.9%. However, I'd wait to see how well it grows organically -- and how it's handling the margin pressure -- before buying the stock and assuming it's a safe blue chip dividend play.

Should you buy stock in Medtronic right now?

Before you buy stock in Medtronic, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Medtronic wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $305,941!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $771,325!*

Now, it’s worth noting Stock Advisor’s total average return is 719% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 21, 2026.

Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Medtronic. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Anthropic Launches New Fable, Mythos Models Ahead of IPO: Up to 30% Speed Boost Poised to Support Offering ValuationTradingKey - Anthropic released Claude Fable 5.2 and Claude Mythos 5.2 on November 9, upgrading their coding, reasoning, and vision capabilities while lowering usage prices. The company stated that ou
Author  TradingKey
Nov 10, Tue
TradingKey - Anthropic released Claude Fable 5.2 and Claude Mythos 5.2 on November 9, upgrading their coding, reasoning, and vision capabilities while lowering usage prices. The company stated that ou
placeholder
Nvidia Enters Bear Market As Google Strikes Amid Jensen Huang's China Spy WoesNvidia, the engine of the AI boom, is in a bear market. Shares sank to about $177 on Monday, 26% below their October record, as a China spy scandal reached its CEO.A bear market means a fall of 20% or
Author  Beincrypto
Nov 10, Tue
Nvidia, the engine of the AI boom, is in a bear market. Shares sank to about $177 on Monday, 26% below their October record, as a China spy scandal reached its CEO.A bear market means a fall of 20% or
placeholder
Nvidia CEO Probe Hit Binance Stock Perps While Wall Street Was ClosedThe probe into Nvidia CEO Jensen Huang broke over the weekend, while Wall Street was closed. Crypto traders still priced it in early. Binance’s Nvidia perpetual futures fell more than 4% below the las
Author  Beincrypto
Nov 10, Tue
The probe into Nvidia CEO Jensen Huang broke over the weekend, while Wall Street was closed. Crypto traders still priced it in early. Binance’s Nvidia perpetual futures fell more than 4% below the las
placeholder
Tesla and SpaceX Stocks Fall as Investors Worry About Elon Musk’s Political RiskWhile the US stock market surged on Wednesday, SpaceX and Tesla stocks were sliding. Democrats won both chambers of Congress and the Texas governor’s race, defeats that land squarely on Elon Musk’s co
Author  Beincrypto
Nov 05, Thu
While the US stock market surged on Wednesday, SpaceX and Tesla stocks were sliding. Democrats won both chambers of Congress and the Texas governor’s race, defeats that land squarely on Elon Musk’s co
placeholder
Brent Crude Plunges 10% Near $90 Level: What Caused the Rapid Drop in Oil Prices?TradingKey - On Wednesday, November 4, Eastern Time, crude oil prices fell sharply, with Brent crude (UKOIL) approaching $93, down over 10% intraday; WTI crude (USOIL) fell below the $87 mark, down mo
Author  TradingKey
Nov 05, Thu
TradingKey - On Wednesday, November 4, Eastern Time, crude oil prices fell sharply, with Brent crude (UKOIL) approaching $93, down over 10% intraday; WTI crude (USOIL) fell below the $87 mark, down mo
goTop
quote